ly 206130 has been researched along with duloxetine hydrochloride in 1 studies
| Studies (ly 206130) | Trials (ly 206130) | Recent Studies (post-2010) (ly 206130) | Studies (duloxetine hydrochloride) | Trials (duloxetine hydrochloride) | Recent Studies (post-2010) (duloxetine hydrochloride) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 1,887 | 441 | 1,073 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engleman, EA; Perry, KW; Robertson, DW; Thompson, DC; Wong, DT | 1 |
1 other study(ies) available for ly 206130 and duloxetine hydrochloride
| Article | Year |
|---|---|
Antagonism of serotonin 5-HT1A receptors potentiates the increases in extracellular monoamines induced by duloxetine in rat hypothalamus.
Topics: Animals; Biogenic Monoamines; Cyclohexylamines; Drug Synergism; Duloxetine Hydrochloride; Extracellular Space; Hypothalamus; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Thiophenes | 1996 |